•
Jun 29, 2024

Thermo Fisher Q2 2024 Earnings Report

Thermo Fisher Scientific reported strong financial performance and share gain in Q2 2024.

Key Takeaways

Thermo Fisher Scientific reported a revenue of $10.54 billion for the second quarter of 2024. GAAP diluted EPS increased by 15% to $4.04, and adjusted EPS increased by 4% to $5.37. The company is raising its full-year revenue and adjusted EPS guidance.

Second quarter revenue was $10.54 billion.

Second quarter GAAP diluted earnings per share (EPS) increased 15% to $4.04.

Second quarter adjusted EPS increased 4% to $5.37.

The company completed its acquisition of Olink, a provider of differentiated next-generation proteomic solutions.

Total Revenue
$10.5B
Previous year: $10.7B
-1.4%
EPS
$5.37
Previous year: $5.15
+4.3%
Gross Profit
$4.34B
Previous year: $4.36B
-0.5%
Cash and Equivalents
$7.07B
Previous year: $3.13B
+125.8%
Free Cash Flow
$1.67B
Previous year: $1.26B
+32.9%
Total Assets
$98.5B
Previous year: $94.1B
+4.7%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher is raising its full-year revenue and adjusted EPS guidance.

Positive Outlook

  • Raising revenue guidance to a new range of $42.4 to $43.3 billion versus its previous guidance of $42.3 to $43.3 billion.
  • Raising adjusted EPS guidance to a new range of $21.29 to $22.07 versus its previous guidance of $21.14 to $22.02.

Revenue & Expenses

Visualization of income flow from segment revenue to net income